The evolving landscape of immunotherapy in lung cancer: From mechanism to clinical translation
Current Proteomics · 2026-06 · 23 (3) · 100121
DOI: 10.1016/j.curpro.2026.100121 ↗Kurz gefasst
Fachartikel in der Zeitschrift Current Proteomics, 2026-06. Verfasst von Zunyu Chen und 7 weiteren Autor:innen. Die Arbeit nennt 172 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Jiangsu University.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Jiangsu University
Zitieren
APA
Chen, Z., Zhang, W., Xiang, M., Wang, Y., Zhu, H., He, M., Shu, Y., & Huang, H. (2026). The evolving landscape of immunotherapy in lung cancer: From mechanism to clinical translation. Current Proteomics, 23(3), 100121. https://doi.org/10.1016/j.curpro.2026.100121
Vancouver
Chen Z, Zhang W, Xiang M, Wang Y, Zhu H, He M, et al. The evolving landscape of immunotherapy in lung cancer: From mechanism to clinical translation. Current Proteomics. 2026;23(3):100121. doi:10.1016/j.curpro.2026.100121
BibTeX
@article{Chen2026,
author = {Chen, Zunyu and Zhang, Wenyu and Xiang, Min and Wang, Yun and Zhu, Haifeng and He, Meijuan and Shu, Yang and Huang, Hanpeng},
title = {The evolving landscape of immunotherapy in lung cancer: From mechanism to clinical translation},
journal = {Current Proteomics},
year = {2026},
volume = {23},
number = {3},
pages = {100121},
doi = {10.1016/j.curpro.2026.100121}
}
EUVIMED